| Literature DB >> 21447187 |
Yan Li1, Kerri Massey, Halina Witkiewicz, Jan E Schnitzer.
Abstract
BACKGROUND: Endothelial cells line all blood vessels to form the blood-tissue interface which is critical for maintaining organ homeostasis and facilitates molecular exchange. We recently used tissue subcellular fractionation combined with several multi-dimensional mass spectrometry-based techniques to enhance identification of lipid-embedded proteins for large-scale proteomic mapping of luminal endothelial cell plasma membranes isolated directly from rat lungs in vivo. The biological processes and functions of the proteins expressed at this important blood-tissue interface remain unexplored at a large scale.Entities:
Year: 2011 PMID: 21447187 PMCID: PMC3080792 DOI: 10.1186/1477-5956-9-15
Source DB: PubMed Journal: Proteome Sci ISSN: 1477-5956 Impact factor: 2.480
Figure 1Enriched biological processes in the membranome. All proteins in the membranome were imported into FatiGO to search possible biological processes in the dataset using the rat knowledge database (see Materials and Methods). The over- or underrepresentation of each category was determined by a Z-score (≥2 or ≤-2, dotted line(s) in the figure). All general categories in biological process included in this data are listed in (a). The subcategories under each general category are organized by GO algorithms and only selected categories are shown: cellular component organization (b), localization (c), metabolic process (d), cellular process (e), biological adhesion (f), and developmental process (g). The bars with vertical stripes indicate the main category from (a); the bars with horizontal stripes indicate the different subcategories in that functional unit; the solid bars are functional terms underneath the horizontal-striped bars, multiple levels can exist under the category of each horizontal-striped bar. Charts are arranged with the top level category at the bottom and resident subcategories above it.
Proteins involved in DNA packaging.
| JSID | Accession | Name | Subcellular specificity |
|---|---|---|---|
| JS40011197 | O88807 | Protein-arginine deiminase type-4 | Cytoplasm |
| JS40071128 | O88764 | Death-associated protein kinase 3 | Nuclear. Relocates to the cytoplasm. |
| JS40026124 | Q923V8 | 15 kDa selenoprotein precursor | Endoplasmic reticulum lumen |
| JS40021817 | Q63945 | Protein SET [Phosphatase 2A inhibitor | Cytoplasm, Endoplasmic reticulum, Nucleus |
| JS40021552 | Q9Z2G8 | Nucleosome assembly protein 1-like 1 | Nucleus, Melanosome |
| JS40048134 | NP_445899.1 | Histone deacetylase 2 | Nucleus |
| JS40016703 | Q6AYU1 | Mortality factor 4-like protein 1 | Nucleus |
| JS40021952 | Q6P747 | Heterochromatin protein 1, binding protein 3 | Nucleus |
Proteins listed were taken from the FatiGO data sheet. From left to right, columns contain: Avatar ID, the accession number from RefSeq/UniProt database, the description of the protein, and the annotated subcellular location.
Figure 2Enriched molecular functions in the membranome. All proteins in the membranome were imported into FatiGO to search for possible molecular functions in the dataset using the rat knowledge database (see Materials and Method). The over- or underrepresentation of each category was determined by a Z-score (≥2 or ≤-2, dotted line(s) in the figure). All general categories included in this data are listed in (a). The subcategories under each general category are organized by GO algorithms and only selected categories are shown: structural molecule activity (b), binding (c), catalytic activity (d), antioxidant activity (e), and transporter activity (f). The solid bars are functional terms under the horizontal-striped bars: see figure 1 for detail.
Figure 3Validation of protein synthesis at the EC PM. The possibility of protein synthesis at the EC PM was investigated by: expansion of translation under biological process to reveal the final over enriched function in this membranome (a); immunoblot analysis to confirm molecules involved in translation in rat lung; H, total tissue homogenates; P, EC PM fraction (b); EM of rat lungs stained with anti-tyrosyl-tRNA synthetase (TyrRS) antibody and gold particles (c) (see Materials and Method). Top panel shows mitochondria (Mt), cytosol (Cyto), and plasma membrane (arrowhead) of endothelial cells (ECs) at the luminal surface of blood vessels. Bottom panel shows both endothelial and epithelial cells. Alv, alveolar; BM, basement membrane; Lu, capillary lumen; WP, Weibel-palade bodies in ECs; and IB, lamella body in epithelial cell. IHC of human normal lung vasculature from Human Protein Atlas (d) (see Materials and Methods). EIF1G, eukaryotic translation initiation factor 1 gamma; SAP130, splicing factor 3b, 130; CA150, transcription elongation factor 1; EIF3 H, eukaryotic translation initiation 3, subunit 9; EIF2, elongation factor 2; EIF5B, eukaryotic translation initiation factor 5B; EIF2S1, eukaryotic translation initiation factor 2, subunit 1 alpha; and TyrRS, Tyrosyl-tRNA synthetase.
Proteins involved in regulation of translational initiation and elongation found in the EC PM membranome.
| JSID | Accession | Description | Ave ng/mg membrane | P/H | Location | IHC (HPA) |
|---|---|---|---|---|---|---|
| JS40004190 | NP_787032 | eukaryotic translation elongation factor 1 alpha 1 | 18258.65 | 2.56 | Cytoplasm | NF |
| JS40005734 | NP_001100433 | eukaryotic translation initiation factor 1A, Y-linked | 2626.9 | 10.755 | undecided | minimal stain |
| JS40005646 | NP_062229 | eukaryotic translation initiation factor 2, subunit 1 alpha | 2308.39 | 6.771 | undecided | vessels |
| JS40001804 | NP_001094012 | eukaryotic translation initiation factor 2, subunit 3 | 775.64 | 16.697 | undecided | no stain on vessels |
| JS40006902 | NP_955412 | Eukaryotic translation initiation factor 2, subunit 2 beta, 38 kDa. | 763.77 | 5.164 | undecided | negative |
| JS40001854 | NP_001102719 | eukaryotic elongation factor, selenocysteine-tRNA-specific | 358.95 | Cytoplasm; Nuclear | negative | |
| JS40020543 | EDM15826 | eukaryotic translation initiation factor 3, subunit 6 interacting protein (Eukaryotic translation initiation factor 3 subunit L) | 317.75 | 1.972 | Cytoplasm cytoplasm; ER; | negative no stain on |
| JS40021548 | XP_226974 | PREDICTED: similar to eukaryotic translation initiation factor 5A2 | 267.31 | 0.258 | cytoplasm; ER; | no stain on |
| JS40011343 | NP_001099762 | eukaryotic translation initiation factor 3, subunit F | 232.31 | 0.329 | Cytoplasm | NT |
| JS50132783 | NP_001032429 | eukaryotic translation initiation factor 6 | 228.67 | Cytoplasm; Nucleus | NT | |
| JS40017299 | NP_001102269 | Eukaryotic translation elongation factor 1 beta 2 | 147.59 | 0.922 | undecided | NT |
| JS40009434 | P05197 | Elongation factor 2. | 125.01 | 0.079 | Cytoplasm | vessels |
| JS40023935 | Q07205 | Eukaryotic translation initiation factor 5. | 97.1 | undecided | minimal stain | |
| JS40005388 | NP_001103611 | eukaryotic translation initiation factor 5B | 96.07 | 4.506 | Cytoplasm | vessels no stain on |
| JS40033059 | NP_001040552 | eukaryotic translation initiation factor 3 subunit A | 92.23 | 0.59 | Cytoplasm | vessels |
| JS40021779 | NP_001099712 | eukaryotic translation initiation factor 3, subunit K | 74.25 | Cytoplasm; nucleus | NT | |
| JS40017420 | NP_001004223 | eukaryotic translation elongation factor 1 gamma | 73.2 | 0.307 | undecided | vessels |
| JS40038166 | Q63186 | Translation initiation factor eIF-2B subunit gamma | 35.96 | undecided | no stain on vessels | |
| JS40041107 | Q64270 | Translation initiation factor eIF-2B subunit alpha | 34.34 | undecided | NT | |
| JS50104474 | Q4G061 | Eukaryotic translation initiation factor 3 subunit B | 29.64 | 0.139 | Cytoplasm | no stain on vessels |
| JS40046084 | NP_001013122 | Eukaryotic translation elongation factor 1 delta. | 24.97 | 0.293 | undecided | NT |
| JS40032823 | Q8VHU4 | Elongator complex protein 1 | 14.96 | cytoplasm; nucleus | NF | |
| JS40020615 | NP_001099307 | eukaryotic translation initiation factor 1 | 14.26 | undecided | NT | |
| JS50042945 | Q3B8Q2 | Eukaryotic initiation factor 4A-III | 11.75 | 0.304 | cytoplasm; nucleus | no stain on vessels vessels |
| JS40069686 | NP_001099765 | Tu translation elongation factor, mitochondrial | 8.17 | 0.07 | Mitochondria | minimal stain |
| JS40039662 | Q6P9U8 | Eukaryotic translation initiation factor 3, subunit 3 gamma, 40 kDa. | 7.31 | 0.18 | Cytoplasm | vessels |
| JS40041278 | P70541 | Translation initiation factor eIF-2B subunit delta | 7.08 | undecided | minimal stain | |
| JS40053968 | NP_001102809 | eukaryotic translation initiation factor 2A | 4.9 | undecided | negative | |
NF: Not Found in HPA; NT: Not Tested by HPA
Protein listed were taken from our rat lung EC PM proteome study published previously [2]. From left to right, columns contain: Avatar ID, the accession number from the RefSeq database, description of the protein, abundance, P/H ratio, annotated subcellular location, and status of IHC analysis in HPA.
Top-ranked protein-protein interaction networks in IPA.
| ID | Top Functions | Score | Focus Molecules |
|---|---|---|---|
| 1 | Cell Morphology, Cellular Development, Cellular Function and Maintenance | 46 | 33 |
| 2 | Lipid Metabolism, Molecular Transport, Small Molecule Biochemistry | 39 | 30 |
| 3 | Cellular Assembly and Organization, Cancer, Reproductive System Disease | 39 | 30 |
| 4 | Cancer, Reproductive System Disease, Cardiovascular System Development and Function | 37 | 29 |
| 5 | Gene Expression, Cell Cycle, Cancer | 35 | 28 |
| 6 | Cell-To-Cell Signaling and Interaction, Immune Response, Cellular Development | 33 | 27 |
| 7 | Inflammatory Disease, Respiratory Disease, Protein Synthesis | 33 | 27 |
| 8 | Cell Signaling, Vitamin and Mineral Metabolism, Cancer | 27 | 24 |
| 9 | Cellular Assembly and Organization, Cellular Compromise, Cell Morphology | 27 | 24 |
| 10 | Cell Signaling, Connective Tissue Disorders, Dermatological Diseases and Conditions | 25 | 23 |
| 11 | Lipid Metabolism, Nucleic Acid Metabolism, Small Molecule Biochemistry | 20 | 20 |
| 12 | Cell-To-Cell Signaling and Interaction, Tissue Development, Cancer | 19 | 19 |
| 13 | Cellular Development, Cell Morphology, Respiratory Disease | 17 | 18 |
| 14 | Cancer, Cellular Movement, Cell Morphology | 16 | 17 |
| 15 | Neurological Disease, Cell Cycle, Genetic Disorder | 16 | 17 |
| 16 | Cancer, Cellular Movement, Cell Morphology | 16 | 17 |
| 17 | Amino Acid Metabolism, Post-Translational Modification, Small Molecule Biochemistry | 16 | 17 |
| 18 | Genetic Disorder, Neurological Disease, Protein Synthesis | 16 | 17 |
| 19 | Cancer, Cell Morphology, Hematological Disease | 15 | 14 |
| 20 | Post-Translational Modification, Protein Folding, Molecular Transport | 14 | 16 |
| 21 | Cell Death, Neurological Disease, Cancer | 14 | 16 |
| 22 | Cellular Function and Maintenance, Small Molecule Biochemistry, Cell Cycle | 14 | 16 |
| 23 | Cell Signaling, Cell Morphology, Cellular Function and Maintenance | 14 | 16 |
| 24 | Gene Expression, Cell-To-Cell Signaling and Interaction, Renal and Urological System Development and Function | 13 | 14 |
| 25 | DNA Replication, Recombination, and Repair, Nucleic Acid Metabolism, Small Molecule Biochemistry | 13 | 15 |
| 26 | Cellular Assembly and Organization, Cell Signaling, Cellular Function and Maintenance | 13 | 15 |
| 27 | Free Radical Scavenging, Cell-To-Cell Signaling and Interaction, Cell Morphology | 13 | 15 |
| 28 | Cellular Function and Maintenance, Cell Signaling, Molecular Transport | 13 | 15 |
| 29 | Gene Expression, RNA Post-Transcriptional Modification, Cancer | 13 | 15 |
| 30 | Cell Cycle, Tissue Development, Gene Expression | 12 | 14 |
| 31 | Cellular Development, Nervous System Development and Function, Tissue Morphology | 12 | 14 |
| 32 | Lipid Metabolism, Molecular Transport, Small Molecule Biochemistry | 10 | 13 |
This table lists all networks having a score ≥10 from the IPA algorithms (see Materials and Methods). From the left to right, ranks from IPA, functions in that rank, score, and the number of molecules from our dataset in that group.
Figure 4Global protein-protein interaction network of the EC PM membranome. All proteins in the EC PM membranome were imported into IPA (see Materials and Methods). Molecules found within the IPA knowledge database (IPAKDB) were applied to the network analysis and only direct relationships among the molecules were allowed. The top 14 networks were merged to create this global map. Known PM- or EC-associated functions are highlighted with blue for EC-associated functions; yellow for neuron-associated functions; green for PM-associated functions; pink for adhesion-associated functions; purple for signaling pathways; light pink for mechanotransduction/mechanosignaling; orange for cell movement and morphology; and white for transport and trafficking. Red nodes indicate enriched proteins in the PM (P/H > 1.0). Green nodes indicate the depletion of the protein in P (P/H < 1.0). The darker the red/green is, the greater the enrichment or depletion. White nodes indicate the proteins were not found in the membranome.
Figure 5Expanded networks of mechanotransduction/mechanosignaling and adhesion. All molecules associated with each function were taken from both figure 4 and our membranome if they were not included in the top 14 networks. Protein-protein associations are indicated by single lines, whereas the arrows indicate the protein controls the other's expression. Only direct protein-protein interaction was allowed in these detailed networks, Mechanotransduction/mechanosignaling (a) and adhesion (b). Each node shape represents a different class of molecule, as shown in (c). Red nodes show that the proteins were enriched in the PM (P/H > 1.0). Green nodes indicate the depletion of the protein in P (P/H < 1.0). The darker the colors are, the greater the enrichment or depletion. White nodes indicate the proteins were not found in our dataset.
Figure 6Expanded networks of transport and signaling pathways. The relationships among the molecules involved in transport (a) and signaling pathways (b) are graphed as described in the text. Integrin-mediated signaling pathway derived by the canonical pathway algorithms of IPA (c). The node colors and shapes are described in figure 5.
Figure 7Network of angiogenesis. This network was created with molecules marked as angiogenesis in figure 4 and molecules in Avatar annotated as angiogenesis but not initially in figure 4. Only direct protein-protein interactions were allowed. See figure 5 for the colors and shapes of the nodes.
Figure 8Network of EC-associated functions. As in figure 7, all molecules associated with EC-related functions and growth of neurites from figure 4 were extracted to generate this network. Only direct protein-protein interactions were allowed in the analysis. See figure 5 for the node colors and shapes.
Proteins involved in neuron-restricted processes found in the EC PM membranome.
| JSID | Accession Number | Description | Quantity (ng/mg membrane) | P/H | Location | Tissue specificity (UniProt & GO) |
|---|---|---|---|---|---|---|
| JS40001915 | Q9Z270 | Vesicle-associated membrane protein-associated protein A [ | 645.54 | 0.523 | Plasma membrane; vesicle | Ubiquitous |
| JS40008100 | NP_001100068 | catenin (cadherin associated protein), alpha 2 (N-catenin) [ | 461.25 | 3.92 | plasma membrane, Cytoskeleton, cell junctioin | Brain |
| JS40003261 | Q9JK11 | Reticulon-4 (nogo) [ | 343.33 | 1.09 | Endoplasmic reticulum | isoform 1 is expressed mainly in the nervous system, Isoforms 2 and 3 are detected in other tissues other than CNS |
| JS40015951 | Q9Z269 | Vesicle-associated membrane protein-associated protein B [ | 267.42 | 0.461 | Plasma membrane; vesicle | Ubiquitous |
| JS40003589 | Q9QWJ9 | Neuropilin-1, CD304 [ | 218.03 | 2.342 | Plasma membrane | Neuron and EC |
| JS40013915 | Q9JLU4 | Shank3 [Proline-rich synapse associated protein 2] [ | 172.77 | 4.844 | Plasma membrane; cytoplasm, synapse | Widely expressed in brain |
| JS40001396 | Q64548 | Reticulon-1 [ | 85.81 | 3.637 | Endoplasmic reticulum | Expressed predominantly in central and peripheral nervous system. isoform RTN1-B is restricted to particular neuronal types |
| JS40046849 | Q6GMN2 | Brain-specific angiogenesis inhibitor 1-associated protein 2 (BAI1A2) [ | 25.66 | Plasma membrane; cytoplasm, cell projection | Ubiquitous | |
| JS40014656 | O08816 | Neural Wiskott-Aldrich syndrome protein (N-Wash) [ | 16.95 | Cytoskeleton; nucleus | NA | |
| JS40028986 | NP_001101576 | Plexin-B2 [ | 14.73 | 0.553 | Plasma membrane | NA |
| JS40004987 | Q63198 | Contactin-1 [Neural cell surface protein F3 [ | 7.97 | Plasma membrane | NA | |
| JS40001709 | Q6RJR6 | Reticulon 3 protein [ | 2 | 416.78 | golgi; ER | many tissues |
| JS40039470 | Q8NFP9 | Neurobeachin [ | 1.85 | Peripheral membrane, cytoplasm | Predominant in many brain structures. Also in many other tissues | |
| JS40011947 | P21263 | Nestin [ | 1.17 | unknown | CNS stem cell | |
Protein listed were taken from our rat lung EC PM proteome study published previously [2]. From left to right, columns contain: Avatar ID, the accession number from the RefSeq database, description of the protein, abundance, P/H ratio, annotated subcellular location, and tissue specificity according to UniProt and GO knowledge databases.
Figure 9Validation of neuron-restricted proteins at the EC PM. The possibility of the neuron-restricted proteins at the EC PM was investigated by: IHC analysis of human normal lung vasculature from Human Protein Atlas with plexin D1 as positive control (a) and EM of rat lungs stained with anti-contactin 1 (top) or anti-neuropilin 1 (bottom) antibody and gold particles (b) (see Materials and Method). Subcellular locations of mitochondrion (Mit), endothelium (Endo), basement membrane (BM), epithelium (Epi), and plasma membrane (arrowhead) of endothelial cells (ECs) at the luminal surface of blood vessels are as indicated in each image.
Figure 10Network of translation initiation and elongation factors. Molecules in this network were derived from table 2. Only direct protein-protein interactions were allowed in the analysis. See figure 5 for the node colors and shapes.